SHELTON, CT / ACCESS Newswire / September 15, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
SAN DIEGO, CA / ACCESS Newswire / September 15, 2026 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company") a...
Toronto, Ontario--(Newsfile Corp. - September 15, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or...
This acquisition expands Endpoint into clinical supply planning while keeping Bluefin independent and RTSM-agnostic.RALEIGH, N.C. and BOSTON, Sept. 14, 2026...
Leading Antibody Discovery Expert Standardizes on the Sapio Scientific AI Platform to Accelerate Delivery for Biotechnology ClientsThe Sapio Scientific AI...
Partnership Leverages FINN's Specialized Experience in Brain Health Communications, Supporting a Shared Mission to Advance Translational Neuroscience WorldwideGENEVA, Sept. 14,...
Sarit Hashkes, President of Filament Health Corp., will provide oral remarks at the United States Food and Drug Administration public...
After scaling revenue at OpenEvidence, GoodRx, and Doximity, Longley steps into the role of Chief Revenue Officer at Outcomes4Me to...
SAN DIEGO, CA / ACCESS Newswire / September 14, 2026 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company") a...
Company Proposes Planned Phase 2b Neoadjuvant Study Following Successful Completion of Phase 1b TrialKing of Prussia, Pennsylvania--(Newsfile Corp. - September...
In a recent interview Vantage Hemp's Chief Medical Officer says healthcare needs standardized, reproducible products and controlled clinical trials -...
FINAL PROSPECTUS ACCESSIBLE ON SEDAR+Vancouver, British Columbia--(Newsfile Corp. - September 11, 2026) - BetterLife Pharma Inc. (CSE: BETR) ("BetterLife" or...
Management to Meet with Investors and Highlight Progress and Future Development Plans for PH-762King of Prussia, Pennsylvania--(Newsfile Corp. - September...
INDIANAPOLIS, Sept. 10, 2026 /PRNewswire/ -- Prominently featured in The Inner Circle, Crystal Risotti is acknowledged as a Pinnacle Professional...
Continuation of treatment with blinded doses of crofelemer in the extension phase of the trial will support company's plans to...
Filament Health has begun planning a stability program for IBEX011, its naturally derived botanical ibogaine drug candidate, in response to...
iPhone users reported significant gains in eye comfort - and preferred Eyesafe® CPF70 Technology nearly 6-to-1 over the baseline solutionMINNEAPOLIS,...
UpDoc awarded up to $9.2 million under ARPA-H's ADVOCATE program to develop and validate an autonomous clinical AI system intended...
Brings total authorized repurchase to $10 millionReflects leadership's view that Aspire-Lakewood's share price does not reflect the Company's financial strength...
NORTHAMPTON, MA / ACCESS Newswire / September 9, 2026 / Organizations Across Sectors Unite Through the Winn Awards to Advance...